BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 33854480)

  • 21. Transforming growth factor-β1/Thrombospondin-1/CD47 axis mediates dysfunction in CD34
    Jahan J; Monte de Oca I; Meissner B; Joshi S; Maghrabi A; Quiroz-Olvera J; Lopez-Yang C; Bartelmez SH; Garcia C; Jarajapu YP
    Eur J Pharmacol; 2022 Apr; 920():174842. PubMed ID: 35217004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blocking thrombospondin-1/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia.
    Isenberg JS; Hyodo F; Pappan LK; Abu-Asab M; Tsokos M; Krishna MC; Frazier WA; Roberts DD
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2582-8. PubMed ID: 17916772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombospondin-1 supports blood pressure by limiting eNOS activation and endothelial-dependent vasorelaxation.
    Bauer EM; Qin Y; Miller TW; Bandle RW; Csanyi G; Pagano PJ; Bauer PM; Schnermann J; Roberts DD; Isenberg JS
    Cardiovasc Res; 2010 Dec; 88(3):471-81. PubMed ID: 20610415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction.
    Rogers NM; Sharifi-Sanjani M; Yao M; Ghimire K; Bienes-Martinez R; Mutchler SM; Knupp HE; Baust J; Novelli EM; Ross M; St Croix C; Kutten JC; Czajka CA; Sembrat JC; Rojas M; Labrousse-Arias D; Bachman TN; Vanderpool RR; Zuckerbraun BS; Champion HC; Mora AL; Straub AC; Bilonick RA; Calzada MJ; Isenberg JS
    Cardiovasc Res; 2017 Jan; 113(1):15-29. PubMed ID: 27742621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thrombospondin-1 regulates bone homeostasis through effects on bone matrix integrity and nitric oxide signaling in osteoclasts.
    Amend SR; Uluckan O; Hurchla M; Leib D; Novack DV; Silva M; Frazier W; Weilbaecher KN
    J Bone Miner Res; 2015 Jan; 30(1):106-15. PubMed ID: 25042340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombospondin-1 modulates VEGF-A-mediated Akt signaling and capillary survival in the developing retina.
    Sun J; Hopkins BD; Tsujikawa K; Perruzzi C; Adini I; Swerlick R; Bornstein P; Lawler J; Benjamin LE
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1344-51. PubMed ID: 19304944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling.
    Isenberg JS; Frazier WA; Krishna MC; Wink DA; Roberts DD
    Curr Drug Targets; 2008 Oct; 9(10):833-41. PubMed ID: 18855617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombospondin-1 triggers cell migration and development of advanced prostate tumors.
    Firlej V; Mathieu JR; Gilbert C; Lemonnier L; Nakhlé J; Gallou-Kabani C; Guarmit B; Morin A; Prevarskaya N; Delongchamps NB; Cabon F
    Cancer Res; 2011 Dec; 71(24):7649-58. PubMed ID: 22037878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombospondin-1 CD47 Signalling: From Mechanisms to Medicine.
    Kale A; Rogers NM; Ghimire K
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner.
    Isenberg JS; Ridnour LA; Perruccio EM; Espey MG; Wink DA; Roberts DD
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13141-6. PubMed ID: 16150726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HDAC6 Suppresses Let-7i-5p to Elicit TSP1/CD47-Mediated Anti-Tumorigenesis and Phagocytosis of Hepatocellular Carcinoma.
    Yang HD; Kim HS; Kim SY; Na MJ; Yang G; Eun JW; Wang HJ; Cheong JY; Park WS; Nam SW
    Hepatology; 2019 Oct; 70(4):1262-1279. PubMed ID: 30991448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valsartan blocks thrombospondin/transforming growth factor/Smads to inhibit aortic remodeling in diabetic rats.
    Sun H; Zhao Y; Bi X; Li S; Su G; Miao Y; Ma X; Zhang Y; Zhang W; Zhong M
    Diagn Pathol; 2015 Apr; 10():18. PubMed ID: 25884585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular TSP1-CD47 signaling promotes sickle cell-associated arterial vasculopathy and pulmonary hypertension in mice.
    Novelli EM; Little-Ihrig L; Knupp HE; Rogers NM; Yao M; Baust JJ; Meijles D; St Croix CM; Ross MA; Pagano PJ; DeVallance ER; Miles G; Potoka KP; Isenberg JS; Gladwin MT
    Am J Physiol Lung Cell Mol Physiol; 2019 Jun; 316(6):L1150-L1164. PubMed ID: 30892078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysosomal integral membrane protein II binds thrombospondin-1. Structure-function homology with the cell adhesion molecule CD36 defines a conserved recognition motif.
    Crombie R; Silverstein R
    J Biol Chem; 1998 Feb; 273(9):4855-63. PubMed ID: 9478926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombospondin-1 is a CD47-dependent endogenous inhibitor of hydrogen sulfide signaling in T cell activation.
    Miller TW; Kaur S; Ivins-O'Keefe K; Roberts DD
    Matrix Biol; 2013 Aug; 32(6):316-24. PubMed ID: 23499828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1.
    Ridnour LA; Isenberg JS; Espey MG; Thomas DD; Roberts DD; Wink DA
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13147-52. PubMed ID: 16141331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombospondin-1 deficiency causes a shift from fibroproliferative to inflammatory kidney disease and delays onset of renal failure.
    Zeisberg M; Tampe B; LeBleu V; Tampe D; Zeisberg EM; Kalluri R
    Am J Pathol; 2014 Oct; 184(10):2687-98. PubMed ID: 25111226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TSP1-CD47-SIRPα signaling facilitates the development of endometriosis by mediating the survival of ectopic endometrium.
    Liu Y; Li M; Wei C; Tang L; Sheng Y; Liu Y; Li D; Ding D; Qiu J; Zhu X
    Am J Reprod Immunol; 2020 Jun; 83(6):e13236. PubMed ID: 32196807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulation of thrombospondin-1(TSP-1) and its binding partners, CD36 and CD47, in sporadic inclusion body myositis.
    Salajegheh M; Raju R; Schmidt J; Dalakas MC
    J Neuroimmunol; 2007 Jul; 187(1-2):166-74. PubMed ID: 17572512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The tryptophan-rich motifs of the thrombospondin type 1 repeats bind VLAL motifs in the latent transforming growth factor-beta complex.
    Young GD; Murphy-Ullrich JE
    J Biol Chem; 2004 Nov; 279(46):47633-42. PubMed ID: 15342643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.